Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
McKesson
AstraZeneca
McKinsey
Dow
Colorcon

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Nitrite

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Nitrite?

Nitrite is an investigational drug.

There have been 91 clinical trials for Nitrite. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2008.

The most common disease conditions in clinical trials are Hypertension, Heart Failure, and Hypertension, Pulmonary. The leading clinical trial sponsors are National Heart, Lung, and Blood Institute (NHLBI), University of Pittsburgh, and Aires Pharmaceuticals, Inc.

Recent Clinical Trials for Nitrite
TitleSponsorPhase
Impact of NOS, COX, and ROS Inhibition on Cerebral Blood Flow RegulationUniversity of Wisconsin, MadisonPhase 1
Tongue Dysbiosis Effects on Arterial Pressure of Periodontitis PatientsConselho Nacional de Desenvolvimento Científico e TecnológicoPhase 4
Tongue Dysbiosis Effects on Arterial Pressure of Periodontitis PatientsUniversity of TaubatePhase 4

See all Nitrite clinical trials

Clinical Trial Summary for Nitrite

Top disease conditions for Nitrite
Top clinical trial sponsors for Nitrite

See all Nitrite clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Colorcon
Baxter
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.